Long-Term Effectiveness of Ethosuximide, Valproic Acid and Lamotrigine in Absence Epilepsy

J Gordon Millichap

doi:10.15844/pedneurbriefs-26-6-3

Long-Term Effectiveness of Ethosuximide, Valproic Acid and Lamotrigine in Absence Epilepsy

Pediatric Neurology Briefs

Volume 26 (2012): Issue 6

By: J Gordon Millichap

Open Access

|Jun 2012

Abstract

Researchers at Seoul National University Bundang and Children’s Hospitals, Republic of Korea evaluated the long-term effectiveness and tolerability of ethosuximide (ESX), valproic acid (VPA), and lamotrigine (LTG) as initial monotherapies for patients with childhood absence epilepsy (CAE).

References

Hwang H Kim H Kim SH Kim SH Lim BC Chae JH Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy Brain Dev 2012 May 34 5 344 348 10.1016/j.braindev.2011.08.007 21893390
Open DOI Search in Google Scholar Back to article
Glauser TA Cnaan A Shinnar S Hirtz DG Dlugos D Masur D Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy N Engl J Med 2010 Mar 4 362 9 790 799 10.1056/NEJMoa0902014 20200383
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-26-6-3 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 42 - 43

Published on: Jun 1, 2012

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Childhood Absence Epilepsy,

Valproic Acid,

Lamotrigine

© 2012 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 26 (2012): Issue 6